Katrine Fladeland Iversen (Katrine F Iversen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Top Venues

Clinical hematology international

Basic & clinical pharmacology & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Katrine Fladeland Iversen
Mechanisms of resistance to daratumumab in patients with multiple myeloma. Basic & clinical pharmacology & toxicology (2024)
Kieran Brennan, Katrine Fladeland Iversen, Alfonso Blanco-Fernández, Thomas Lund, Torben Plesner, Margaret M Mc Gee
Extracellular Vesicles Isolated from Plasma of Multiple Myeloma Patients Treated with Daratumumab Express CD38, PD-L1, and the Complement Inhibitory Proteins CD55 and CD59. Cells 11 (21) (2022)
Katrine Fladeland Iversen, Line Nederby, Thomas Lund, Torben Plesner
High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4 + T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens. Clinical hematology international 4 (3) (2022)
Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Niels Emil Ulrich Hermansen, Lise Mette Rahbek Gjerdrum, Søren Thorgaard Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Katrine Fladeland Iversen, Elena Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Strandholdt, Mette Klarskov Andersen, Annette Juul Vangsted
The real-world outcomes of multiple myeloma patients treated with daratumumab. PloS one 16 (10) (2021)